Last year, it was reported that upwards of 1 out of 4 IVs placed will be dislodged. This statistic increases when we look at geriatric, pediatric, and dementia patients, as they often try to remove the catheters due to discomfort or confusion. Potential complications associated with IV dislodgement include infections, trauma to the area, and the disruption of essential and even time-sensitive care. Thus, we created AnchorCath as a way to address patient and healthcare provider concerns. AnchorCath’s novel design relies on a flat connector with a bio-safe silicone base placed between the catheter itself and the IV extension in a “u” shape. Our device redirects the force applied to the catheter when it’s tugged on to increase the amount of pull needed to achieve dislodgement. It’s flat silicon contact surface provides an improved grip, reducing the need for extra adhesive, which is a game changer for geriatric patients with fragile and loose skin who often face complications with current adhesives. AnchorCath allows patients to have a better experience whether it is in a hospital or during home care, as less adhesive means a decrease in irritation incidents and skin tearing in an already at-risk population. AnchorCath’s convenient design fits with all Intravenous catheter sizes and introduces a new point for the device to disconnect prior to site dislodgement, which allows the line to be reconnected in most cases without having to puncture the patient’s skin again.AnchorCath is also an easy-adaptable solution for hospitals around the US. It’s intuitive design and easy mechanism of attachment means that hospitals can implement this important addition without the need for extensive training, and its price point compared to the amount of tape and extra adhesive needed to achieve similar levels of securement makes it a very compelling device.